A unique range of over 3000 novel substituted fluoro aromatic compounds functionalised with a variety of synthetically useful reactive groups.
The divestment is expected to complete in the first quarter of 2020, subject to customary closing conditions and regulatory clearances.
Read More >
Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >